Key result
Statins and other anti-inflammatory interventions show mixed evidence for the prevention and treatment of atrial fibrillation across recent studies, warranting further randomized trials.
Why the study?
Do anti-inflammatory interventions such as statins reduce the incidence or recurrence of atrial fibrillation?
Do anti-inflammatory interventions such as statins reduce the incidence or recurrence of atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This editorial highlights the mixed evidence regarding the efficacy of statins and other anti-inflammatory drugs in preventing or treating atrial fibrillation across different patient populations.
We read with great interest the recent elegant review of Boos et al.,1 which presents an overview of the evidence of inflammation and anti-inflammatory therapies in atrial fibrillation (AF). We agree with the reviewers that some drugs which have anti-inflammatory characteristics, such as ACE-inhibitors, ARBs, statins, steroids, fish oils, and vitamin C, might be useful in the management of AF.2,3 In addition, we would like to add some new evidence of anti-inflammatory interventions in AF. Recently, another two studies evaluated the role of statins in the prevention and treatment of AF. Marin et al.4 studied 234 consecutive patients who underwent coronary artery bypass grafting (CABG) and observed that statin use was significantly associated with a decreased incidence of post-operative AF and increased TIMP1/MMP1 ratio. In a single-blind prospective study, Dernellis et al.5 randomized 80 patients with paroxysmal AF to atorvastatin or placebo. After 4–6 months of therapy, treatment group exhibited a highly significant reduction in paroxysmal AF and C-reactive protein levels. However, in a recent post hoc analysis of a large randomized clinical trial, MIRACL study,6 intensive statin treatment did not appear to prevent new AF in the 16 weeks following acute coronary syndrome. Therefore, more randomized trials of statins in patients with AF may be warranted.
No takes yet. Share an insight, caveat, or question.
Tong Liu (2005) conducted a letter in Atrial fibrillation. Statins and other anti-inflammatory interventions was evaluated. Statins and other anti-inflammatory interventions show mixed evidence for the prevention and treatment of atrial fibrillation across recent studies, warranting further randomized trials.
Synapse has enriched 10 related papers. Consider them for comparative context: